Gene · 27329
Papers2,231
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,231
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pemafibrate Increases Circulating Angiopoietin-like Proteins 3 and 4 Without Promoting Pro-Atherogenic Changes in LDL and HDL Subspecies: A Post-Hoc Analysis of the PRESTIGE Study. | J Atheroscler Thromb | 2026 | 41047339 | PubTator, text mining | PubMed |
| Advances in Non-statin Lipid Therapies: A Narrative Review of Evolving Strategies for Cardiovascular Risk Reduction. | Am J Cardiovasc Drugs | 2026 | 40884609 | PubTator, text mining | PubMed |
| Assessment of Pediatric Hypertriglyceridemia Etiology: Insights from Next-Generation Sequencing Panels and Identification of Novel Variants. | Biochem Genet | 2026 | 40773003 | PubTator, text mining | PubMed |
| 2025: The year in cardiovascular disease - the year of triglyceride lowering therapies. Can we effectively reduce triglyceride-related residual cardiovascular disease and pancreatitis risk? | Arch Med Sci | 2025 | 41676432 | PubTator, text mining | PubMed |
| Identification of prognostic biomarkers and development of a prediction model for prostate cancer. | Front Immunol | 2025 | 41562091 | PubTator, text mining | PubMed |
| ANGPTL3 and residual atherosclerotic risk: from lipid metabolism to therapeutic targeting. | Front Endocrinol (Lausanne) | 2025 | 41561063 | PubTator, text mining | PubMed |
| [Correlation of Serum Neuron-Specific Enolase, Angiopoietin-1, and Angiopoietin-Like Protein-3 With Disease Severity and Their Prognostic Value in Patients With Cerebral Infarction]. | Sichuan Da Xue Xue Bao Yi Xue Ban | 2025 | 41536654 | PubTator, text mining | PubMed |
| Impact of Bariatric Surgery Type on Adipokines, Myokines, and Hepatokines: An 18-Month Prospective, Observational, Open-Label Study. | Physiol Res | 2025 | 41511104 | PubTator, text mining | PubMed |
| Individuals whose phenotype deviates from genetic expectation defined by common variation are enriched for rare damaging variants in genes that cause rare disease. | medRxiv | 2025 | 41503465 | PubTator, text mining | PubMed |
| Editorial: Lipidology at the Dawn of a New Era. | Diabetes Metab Syndr Obes | 2025 | 41451312 | PubTator, text mining | PubMed |
| Genetic association of lipid-lowering drug target genes with cholecystitis: A summary-data-based Mendelian randomization analysis. | Medicine (Baltimore) | 2025 | 41327716 | PubTator, text mining | PubMed |
| The "Now" and "Next" in Precision Cardiovascular Medicine. | Biomedicines | 2025 | 41301790 | PubTator, text mining | PubMed |
| Genetic Assessment and Clinical Correlates in Severe Hypertriglyceridemia: A Systematic Review. | Genes (Basel) | 2025 | 41300829 | PubTator, text mining | PubMed |
| Lipid deprivation amplifies type I IFN responses in monocytes through prenylation: insights from familial combined hypolipidemia type 2. | J Transl Med | 2025 | 41291732 | PubTator, text mining | PubMed |
| Integrative functional genomics reveals transcriptional regulatory function of risk alleles for metabolic liver disease. | Res Sq | 2025 | 41282202 | PubTator, text mining | PubMed |
| Phase 1 Trial of CRISPR-Cas9 Gene Editing Targeting ANGPTL3. | N Engl J Med | 2025 | 41211945 | PubTator, text mining | PubMed |
| Innovative Lipid-Lowering Strategies: RNA-Based, Small Molecule, and Protein-Based Therapies. | Endocrinol Metab (Seoul) | 2025 | 41208263 | PubTator, text mining | PubMed |
| Synergic combination of the monogenic ANGPTL3 p.H343R variant and a polygenic predisposition in a family with hypobetalipoproteinemia. | Atherosclerosis | 2025 | 41206978 | PubTator, text mining | PubMed |
| Future of angiopoietin-like protein 3 inhibitors as a therapeutic agent. | Curr Opin Lipidol | 2025 | 41190668 | PubTator, text mining | PubMed |
| Paracrine Signaling by Distinct Adipose Tissue Depots Regulate Fibroblast Mechanobiology and Functional Heterogeneity. | Cell Mol Bioeng | 2025 | 41185635 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/27329/papers?page=8